BIOMAT Database Logo BIOMAT Database Logo

Morphometric analysis of AgNORs in uveal malignant melanoma. 1998

S Staibano, and P Orabona, and E Mezza, and G Salvatore, and F Tranfa, and D Capone, and M E Errico, and G Bonavolontà, and A Lucariello, and G De Rosa
Department of Morphological and Functional Sciences, Faculty of Medicine and Surgery, Federico II University, Naples, Italy.

OBJECTIVE To define the value of silver-stained nucleolar organizer regions (AgNOR) in the evaluation of uveal malignant melanomas (MM). METHODS Morphometric analysis of AgNORs was performed on 30 uveal MM of spindle A, B, epithelioid and mixed cell types. Findings were compared with cytotype, largest tumor dimension (LTD) and clinical outcome. RESULTS AgNOR mean perimeter (MP) was 3.76 microns (SD 1.21, range 1.79-8.51 microns) in A, 5.05 microns (SD 1.96, range 1.79-16.41 microns) in B and 6.15 microns (SD 3.86, range 1.79-33.80 microns) in epithelioid MM; mean area (MA) was 0.86 micron 2 (SD 0.60, range 0.20-2.78 microns 2) in A, 1.58 microns 2 (SD 1.11, range 0.20-9.63 microns 2) in B and 2.34 microns 2 (SD 2.10, range 0.20-15.27 microns 2) in epithelioid MM; the aspect ratio (AR) was 3.10 (SD 0.19, range 2.90-3.35) in A, 5.80 (SD 2.07, range 3.77-9.32) in B and 12.22 (SD 2.84, range 8.11-15.81) in epithelioid MM. From comparing MA and RA with follow-up, it seemed that MM with a good prognosis (spindle A and a subgroup of B tumors, B1) exhibited the lowest MA and AR values, while MM with poorer clinical behavior (epithelioid and a second subgroup of spindle B MM, B2) showed the highest. No correlation was found between AgNORs and LTD. CONCLUSIONS AgNORs may contribute to the prognostic evaluation of uveal MM.

UI MeSH Term Description Entries
D007091 Image Processing, Computer-Assisted A technique of inputting two-dimensional or three-dimensional images into a computer and then enhancing or analyzing the imagery into a form that is more useful to the human observer. Biomedical Image Processing,Computer-Assisted Image Processing,Digital Image Processing,Image Analysis, Computer-Assisted,Image Reconstruction,Medical Image Processing,Analysis, Computer-Assisted Image,Computer-Assisted Image Analysis,Computer Assisted Image Analysis,Computer Assisted Image Processing,Computer-Assisted Image Analyses,Image Analyses, Computer-Assisted,Image Analysis, Computer Assisted,Image Processing, Biomedical,Image Processing, Computer Assisted,Image Processing, Digital,Image Processing, Medical,Image Processings, Medical,Image Reconstructions,Medical Image Processings,Processing, Biomedical Image,Processing, Digital Image,Processing, Medical Image,Processings, Digital Image,Processings, Medical Image,Reconstruction, Image,Reconstructions, Image
D008545 Melanoma A malignant neoplasm derived from cells that are capable of forming melanin, which may occur in the skin of any part of the body, in the eye, or, rarely, in the mucous membranes of the genitalia, anus, oral cavity, or other sites. It occurs mostly in adults and may originate de novo or from a pigmented nevus or malignant lentigo. Melanomas frequently metastasize widely, and the regional lymph nodes, liver, lungs, and brain are likely to be involved. The incidence of malignant skin melanomas is rising rapidly in all parts of the world. (Stedman, 25th ed; from Rook et al., Textbook of Dermatology, 4th ed, p2445) Malignant Melanoma,Malignant Melanomas,Melanoma, Malignant,Melanomas,Melanomas, Malignant
D009697 Nucleolus Organizer Region The chromosome region which is active in nucleolus formation and which functions in the synthesis of ribosomal RNA. Nucleolar Organizer,Nucleolar Organizers,Nucleolus Organizer Regions,Organizer Region, Nucleolus,Organizer Regions, Nucleolus,Organizer, Nucleolar,Organizers, Nucleolar,Region, Nucleolus Organizer,Regions, Nucleolus Organizer
D011379 Prognosis A prediction of the probable outcome of a disease based on a individual's condition and the usual course of the disease as seen in similar situations. Prognostic Factor,Prognostic Factors,Factor, Prognostic,Factors, Prognostic,Prognoses
D005500 Follow-Up Studies Studies in which individuals or populations are followed to assess the outcome of exposures, procedures, or effects of a characteristic, e.g., occurrence of disease. Followup Studies,Follow Up Studies,Follow-Up Study,Followup Study,Studies, Follow-Up,Studies, Followup,Study, Follow-Up,Study, Followup
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D014604 Uveal Neoplasms Tumors or cancer of the UVEA. Neoplasm, Uveal,Neoplasms, Uveal,Uveal Neoplasm
D016622 Silver Staining The use of silver, usually silver nitrate, as a reagent for producing contrast or coloration in tissue specimens. Silver Nitrate Staining,Nitrate Staining, Silver,Staining, Silver,Staining, Silver Nitrate

Related Publications

S Staibano, and P Orabona, and E Mezza, and G Salvatore, and F Tranfa, and D Capone, and M E Errico, and G Bonavolontà, and A Lucariello, and G De Rosa
Morphometric analysis of AgNORs in uveal malignant melanoma.
April 2000, Analytical and quantitative cytology and histology,
S Staibano, and P Orabona, and E Mezza, and G Salvatore, and F Tranfa, and D Capone, and M E Errico, and G Bonavolontà, and A Lucariello, and G De Rosa
[Uveal malignant melanoma].
January 1993, Harefuah,
S Staibano, and P Orabona, and E Mezza, and G Salvatore, and F Tranfa, and D Capone, and M E Errico, and G Bonavolontà, and A Lucariello, and G De Rosa
Congenital uveal malignant melanoma.
April 2014, Journal of AAPOS : the official publication of the American Association for Pediatric Ophthalmology and Strabismus,
S Staibano, and P Orabona, and E Mezza, and G Salvatore, and F Tranfa, and D Capone, and M E Errico, and G Bonavolontà, and A Lucariello, and G De Rosa
Morphometric analysis of AgNORs in the lymph node lesions.
April 2002, Advances in clinical pathology : the official journal of Adriatic Society of Pathology,
S Staibano, and P Orabona, and E Mezza, and G Salvatore, and F Tranfa, and D Capone, and M E Errico, and G Bonavolontà, and A Lucariello, and G De Rosa
Incidence of uveal malignant melanoma.
September 1979, American journal of ophthalmology,
S Staibano, and P Orabona, and E Mezza, and G Salvatore, and F Tranfa, and D Capone, and M E Errico, and G Bonavolontà, and A Lucariello, and G De Rosa
[A survival analysis of patients with malignant uveal melanoma].
January 2000, Oftalmologia (Bucharest, Romania : 1990),
S Staibano, and P Orabona, and E Mezza, and G Salvatore, and F Tranfa, and D Capone, and M E Errico, and G Bonavolontà, and A Lucariello, and G De Rosa
Uveal malignant melanoma with leucoderma.
June 1968, Journal of the All-India Ophthalmological Society,
S Staibano, and P Orabona, and E Mezza, and G Salvatore, and F Tranfa, and D Capone, and M E Errico, and G Bonavolontà, and A Lucariello, and G De Rosa
Malignant canine anterior uveal melanoma.
November 1989, Veterinary pathology,
S Staibano, and P Orabona, and E Mezza, and G Salvatore, and F Tranfa, and D Capone, and M E Errico, and G Bonavolontà, and A Lucariello, and G De Rosa
Brachytherapy for malignant uveal melanoma.
March 2014, Tidsskrift for den Norske laegeforening : tidsskrift for praktisk medicin, ny raekke,
S Staibano, and P Orabona, and E Mezza, and G Salvatore, and F Tranfa, and D Capone, and M E Errico, and G Bonavolontà, and A Lucariello, and G De Rosa
[An extremely malignant uveal melanoma].
March 1987, Rontgen-Blatter; Zeitschrift fur Rontgen-Technik und medizinisch-wissenschaftliche Photographie,
Copied contents to your clipboard!